"A Phase II open-label, single-arm, multi-center study of ruxolitinib added to corticosteroids in pediatric subjects with moderate and severe chronic graft vs. host disease after allogeneic stem cell transplantation"
2022-06-27
عنوان الدراسة
"A Phase II open-label, single-arm, multi-center study of ruxolitinib added to corticosteroids in pediatric subjects with moderate and severe chronic graft vs. host disease after allogeneic stem cell transplantation"
داعم الدراسة
Novartis
دواء الدراسة
ruxolitinib
رقم بروتوكول الدراسة
CINC424G12201
حالة الدراسة
Completed
موقع الدراسة
KFSH&RC-R
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.